Angela Gutermuth

Fraunhofer Institute for Production Technology IPT

Papers

Total Citations

H-Index

About

Angela Gutermuth has carved a distinctive niche at the intersection of biomedical engineering and regenerative medicine, with a primary focus on developing scalable, cGMP-compliant methods for cell extraction. Her most cited work, "Automated Tissue Dissociation for Rapid Extraction of Viable Cells" (2017, 5 citations), addresses a critical bottleneck in the therapeutic cell supply chain: the labor-intensive and highly variable process of liberating viable cells from dense connective tissue matrices. By pioneering an automated dissociation platform, Gutermuth has directly tackled the challenge of high variability that historically hindered compliance with current Good Manufacturing Practices. This contribution is foundational for next-generation cell therapies and regenerative medicine applications, where a consistent, high-yield source of viable cells is paramount. Her research not only reduces manual labor but also enhances reproducibility, a key requirement for clinical translation. While her citation count is modest, the practical impact of her work is significant, providing a crucial enabling technology for researchers and manufacturers seeking to scale up cell-based therapeutics from bench to bedside.